(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

U.S. District Judge Dale Ho said Adams failed to demonstrate that federal prosecutors leaked grand jury secrets to the media, ...

Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...

Just over 25 years ago, MYC, the human homologue of a retroviral oncogene, was identified. Since that time, MYC research has been intense and the advances impressive. On reflection, it is ...

Midcoast Youth Center & Skatepark will host Strengthening Families Program (SFP) facilitator training Friday through Sunday, ...

Complementary to other molecular techniques: OGM provides a complementary approach by revealing large structural variations that may be missed by methods like next-generation sequencing (NGS). A ...

The Phase 1 monotherapy dose escalation portion of MYCHELANGELO I was designed to evaluate the safety, tolerability, pharmacokinetics, ...

Multiple myeloma, a hematologic cancer, is marked by genetic abnormalities, including MYC gene rearrangements. The study showed that OGM detected MYC-positive cases in 40% of instances compared to ...